These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7272185)

  • 1. Mice treated with strontium 90: an animal model deficient in NK cells.
    Emmanuel FX; Vaughan AT; Catty D
    Br J Cancer; 1981 Aug; 44(2):160-5. PubMed ID: 7272185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice.
    Warner NL; Woodruff MF; Burton RC
    Int J Cancer; 1977 Jul; 20(1):146-55. PubMed ID: 903182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of natural killer cells in the early period of infection in murine cutaneous leishmaniasis.
    Laurenti MD; Gidlund M; Ura DM; Sinhorini IL; Corbett CE; Goto H
    Braz J Med Biol Res; 1999 Mar; 32(3):323-5. PubMed ID: 10347791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 90Sr on mouse natural killer cells and their regulation by alpha interferon and interleukin 2.
    Gidlund M; Bierke P; Orn A; Axberg I; Ramstedt U; Wigzell H
    Scand J Immunol; 1990 May; 31(5):575-82. PubMed ID: 2140623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice.
    Martiniello R; Burton RC; Smart YC
    Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse.
    Clark EA; Russell PH; Egghart M; Horton MA
    Int J Cancer; 1979 Nov; 24(5):688-99. PubMed ID: 93585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.
    Chow DA; Greene MI; Greenberg AH
    Int J Cancer; 1979 Jun; 23(6):788-97. PubMed ID: 223992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
    Kärre K; Klein GO; Kiessling R; Klein G
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of natural killer cells in the mouse.
    Lust JA; Kumar V; Burton RC; Bartlett SP; Bennett M
    J Exp Med; 1981 Aug; 154(2):306-17. PubMed ID: 7264561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late immune and haemopoietic functions in plasmacytoma-bearing mice cured by melphalan.
    Sagi O; Witz IP; Ramot B; Sahar E; Douer D
    Br J Cancer; 1988 Mar; 57(3):271-6. PubMed ID: 3258523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of growth of tumours in NC-cell-depleted mice with NC- and NK-cell-mediated lysis in vitro.
    Smart YC; Farrelly ML; Burton RC
    Int J Cancer; 1992 Mar; 50(5):817-21. PubMed ID: 1544715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
    Hackett J; Bennett M; Kumar V
    J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on natural killer (NK) cells. II. Serologic evidence for heterogeneity of murine NK cells.
    Burton RC; Bartlett SP; Kumar V; Winn HJ
    J Immunol; 1981 Nov; 127(5):1864-8. PubMed ID: 6975301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cytotoxicity of haemopoietic cell populations against murine lymphoid tumours.
    Burton RC; Grail D; Warner NL
    Br J Cancer; 1978 May; 37(5):806-17. PubMed ID: 656308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent.
    Haller O; Wigzell H
    J Immunol; 1977 Apr; 118(4):1503-6. PubMed ID: 300411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
    J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.